Search - tctmd.com

Displaying 381 - 400 of 480

Sort: Relevancy | Date

Presentation

Intracranial Hemorrhage Among Patients with A-Fib Anticoagulated with Warfarin or Rivaroxaban

Presenter: Graeme J. Hankey

April 22, 2014

Presentation Fellows 2014

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: William Gray

April 14, 2014

Presentation ECHO 2014

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Presenter: James D. Thomas

April 11, 2014

Presentation

Poorly Controlled Blood Pressure Is Independently Associated with 50% Higher Risk of Stroke or Systemic Embolism in A-fib Patients

Presenter: Meena Rao

April 02, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Presenter: T. Tanawuttiwat

January 29, 2014

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

Presentation

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Presenter: C.T. Ruff

December 15, 2013

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

Presentation

Efficacy and Safety of Apixaban Following Cardioversion for A-fib: ARISTOTLE Insights

Presenter: Greg Flaker

November 14, 2013

Presentation TCT 2013

DES Implantation in a Patient with Atrial Fibrillation

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Presenter: Piotr Musialek

October 29, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Presentation

Case 4: Patient with Atrial Fibrillation and DES

Presenter: Roxana Mehran

October 29, 2013

Advertisement

Intracranial Hemorrhage Among Patients with A-Fib Anticoagulated with Warfarin or Rivaroxaban

LAA Closure for Nonvalvular Atrial Fibrillation

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Poorly Controlled Blood Pressure Is Independently Associated with 50% Higher Risk of Stroke or Systemic Embolism in A-fib Patients

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Efficacy and Safety of Apixaban Following Cardioversion for A-fib: ARISTOTLE Insights

DES Implantation in a Patient with Atrial Fibrillation

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Case 4: Patient with Atrial Fibrillation and DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content